Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin

Insulin-like growth factors control numerous processes, namely somatic growth, metabolism and stress resistance, connecting this pathway to aging and age-related diseases. Insulin-like growth factor signaling also impacts on neurogenesis, neuronal survival and structural plasticity. Recent reports demonstrated that diminished insulin-like growth factor signaling confers increased stress resistance in brain and other tissues. To better understand the role of neuronal insulin-like growth factor signaling in neuroprotection, we inactivated insulin-like growth factor type-1-receptor in forebrain neurons using conditional Cre-LoxP-mediated gene targeting. We found that brain structure and function, including memory performance, were preserved in insulin-like growth factor receptor mutants, and that certain characteristics improved, notably synaptic transmission in hippocampal neurons. To reveal stress-related roles of insulin-like growth factor signaling, we challenged the brain using a stroke-like insult. Importantly, when charged with hypoxia-ischemia, mutant brains were broadly protected from cell damage, neuroinflammation and cerebral edema. We also found that in mice with insulin-like growth factor receptor knockout specifically in forebrain neurons, a substantial systemic upregulation of growth hormone and insulin-like growth factor-I occurred, which was associated with significant somatic overgrowth. Collectively, we found strong evidence that blocking neuronal insulin-like growth factor signaling increases peripheral somatotropic tone and simultaneously protects the brain against hypoxic–ischemic injury, findings that may contribute to developing new therapeutic concepts preventing the disabling consequences of stroke.

[1]  A. Messina,et al.  Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease , 2015, The Journal of Neuroscience.

[2]  M. Holzenberger,et al.  Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance , 2015, The Journal of Neuroscience.

[3]  P. Jedlicka,et al.  Deletion of the amyloid precursor‐like protein 1 (APLP1) enhances excitatory synaptic transmission, reduces network inhibition but does not impair synaptic plasticity in the mouse dentate gyrus , 2015, The Journal of comparative neurology.

[4]  Hugues Berry,et al.  Suppression of IGF-I signals in neural stem cells enhances neurogenesis and olfactory function during aging , 2015, Aging cell.

[5]  J. Mozrzymas,et al.  Impact of matrix metalloproteinase-9 overexpression on synaptic excitatory transmission and its plasticity in rat CA3-CA1 hippocampal pathway. , 2015, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[6]  P. Maity,et al.  Superoxide anion radicals induce IGF-1 resistance through concomitant activation of PTP1B and PTEN , 2014, EMBO molecular medicine.

[7]  Z. Ungvari,et al.  Endothelin-1-induced focal cerebral ischemia in the growth hormone/IGF-1 deficient Lewis Dwarf rat. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[8]  J. Simpkins,et al.  mTOR Signaling Inhibition Modulates Macrophage/Microglia-Mediated Neuroinflammation and Secondary Injury via Regulatory T Cells after Focal Ischemia , 2014, The Journal of Immunology.

[9]  F. Metzger,et al.  Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1. , 2014, Brain : a journal of neurology.

[10]  I. Torres-Aleman,et al.  Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury , 2014, F1000Research.

[11]  J. Dupont,et al.  Longevity effect of IGF-1R+/− mutation depends on genetic background-specific receptor activation , 2013, Aging cell.

[12]  Wenhua Zheng,et al.  Glutamate attenuates IGF-1 receptor tyrosine phosphorylation in mouse brain: Possible significance in ischemic brain damage , 2012, Neuroscience Research.

[13]  E. Benarroch Insulin-like growth factors in the brain and their potential clinical implications , 2012, Neurology.

[14]  J. Schneider,et al.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.

[15]  D. Munoz,et al.  An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. , 2012, The Journal of clinical investigation.

[16]  I. Torres-Aleman,et al.  The many faces of insulin-like peptide signalling in the brain , 2012, Nature Reviews Neuroscience.

[17]  R. Kulkarni,et al.  Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion. , 2011, Gastroenterology.

[18]  C. Bass,et al.  Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression , 2011, Neuroscience.

[19]  P. Ye,et al.  Blunting type 1 insulin-like growth factor receptor expression exacerbates neuronal apoptosis following hypoxic/ischemic injury , 2011, BMC Neuroscience.

[20]  Federica Madia,et al.  Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans , 2011, Science Translational Medicine.

[21]  Sarah A. Stern,et al.  A critical role for IGF-II in memory consolidation and enhancement , 2011, Nature.

[22]  Angel Nuñez,et al.  Neuronal Activity Drives Localized Blood-Brain-Barrier Transport of Serum Insulin-like Growth Factor-I into the CNS , 2010, Neuron.

[23]  Ehud Cohen,et al.  Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection , 2010, Aging cell.

[24]  Rosemary O’Connor,et al.  Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling , 2010, Neurobiology of Aging.

[25]  Pablo Blinder,et al.  Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice , 2009, Cell.

[26]  A. Aleman,et al.  Circulating insulin-like growth factor I and cognitive function: Neuromodulation throughout the lifespan , 2009, Progress in Neurobiology.

[27]  T. Kadowaki,et al.  Neuronal IGF‐1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  W. Young,et al.  Postischemic IGF-1 Gene Transfer Promotes Neurovascular Regeneration after Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  F. Tronche,et al.  IGF-1R contributes to stress-induced hepatocellular damage in experimental cholestasis. , 2009, The American journal of pathology.

[30]  Sang-H Choi,et al.  The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. , 2009, Trends in pharmacological sciences.

[31]  M. Blüher,et al.  Autocrine IGF-1 Action in Adipocytes Controls Systemic IGF-1 Concentrations and Growth , 2008, Diabetes.

[32]  M. Endres,et al.  Serum insulin-like growth factor I and ischemic brain injury , 2007, Brain Research.

[33]  I. Torres-Aleman,et al.  Targeting insulin-like growth factor-1 to treat Alzheimer's disease , 2007, Expert opinion on therapeutic targets.

[34]  Mary F. Lopez,et al.  IGF2 knockout mice are resistant to kainic acid-induced seizures and neurodegeneration , 2007, Brain Research.

[35]  A. Shuaib,et al.  Critical role of microvasculature basal lamina in ischemic brain injury , 2007, Progress in Neurobiology.

[36]  I. Torres-Aleman,et al.  Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects , 2007, Molecular Psychiatry.

[37]  I. Torres-Aleman,et al.  Calcineurin in Reactive Astrocytes Plays a Key Role in the Interplay between Proinflammatory and Anti-Inflammatory Signals , 2007, The Journal of Neuroscience.

[38]  B. Bu,et al.  Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo , 2007, Glia.

[39]  Bruno Giros,et al.  Parallel Loss of Hippocampal LTD and Cognitive Flexibility in a Genetic Model of Hyperdopaminergia , 2007, Neuropsychopharmacology.

[40]  F. Tronche,et al.  Hepatocyte proliferation during liver regeneration is impaired in mice with liver‐specific IGF‐1R knockout , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  P. Gluckman,et al.  The insulin-like growth factor system and its pleiotropic functions in brain. , 2005, Endocrine reviews.

[42]  M. Holzenberger,et al.  Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury , 2005, Respiratory research.

[43]  I. Torres-Aleman,et al.  Insulin-like growth factor I is required for vessel remodeling in the adult brain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  David R. Kaplan,et al.  ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3 , 2004, The Journal of cell biology.

[45]  R. Swanson,et al.  Astrocyte influences on ischemic neuronal death. , 2004, Current molecular medicine.

[46]  J. Dupont,et al.  Biology of insulin-like growth factors in development. , 2003, Birth defects research. Part C, Embryo today : reviews.

[47]  I. Torres-Aleman,et al.  Glutamate excitotoxicity attenuates insulin-like growth factor-i prosurvival signaling , 2003, Molecular and Cellular Neuroscience.

[48]  A. Gunn,et al.  Insulin-like growth factor-1 and post-ischemic brain injury , 2003, Progress in Neurobiology.

[49]  I. Robinson,et al.  Growth hormone-releasing hormone (GHRH) neurons in GHRH-enhanced green fluorescent protein transgenic mice: a ventral hypothalamic network. , 2003, Endocrinology.

[50]  I. Torres-Aleman,et al.  Brain repair and neuroprotection by serum insulin-like growth factor I , 2003, Molecular Neurobiology.

[51]  Martin Holzenberger,et al.  IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.

[52]  J. Argente,et al.  Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. , 2002, Endocrinology.

[53]  S. Vannucci,et al.  IGF‐I and microglia/macrophage proliferation in the ischemic mouse brain , 2002, Glia.

[54]  S. Vannucci,et al.  Experimental Stroke in the Female Diabetic, db/db, Mouse , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  S. Orkin,et al.  Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Staiger,et al.  Efferent projections from the lateral septal nucleus to the anterior hypothalamus in the rat: A study combining Phaseolus vulgaris-leucoagglutinin tracing with vasopressin immunocytochemistry , 1990, Cell and Tissue Research.

[57]  I. Torres-Aleman,et al.  Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury. , 2014, F1000Research.

[58]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[59]  S. Vannucci,et al.  Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice. , 2004, The Journal of clinical investigation.

[60]  Wolfgang Schmid,et al.  Disruption of CREB function in brain leads to neurodegeneration , 2002, Nature Genetics.

[61]  S. Levine,et al.  Anoxic-ischemic encephalopathy in rats. , 1960, The American journal of pathology.